All In MedTech

Device Trial Radar · NCT03884647

DELPHI in Subjects at Risk for Stroke and Dementia

DELPHI Software for the Analysis of TMS-EEG Data of Brain Functionality - in Subjects at Risk for Stroke and Dementia

Last checked: Nov 20, 2026Latest source record: Sep 14, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

335

Actual

Start

Apr 1, 2020

Primary completion

May 6, 2022

Study completion May 6, 2022

Sponsor

Lead sponsor
QuantalX NeuroscienceNot on our public-company list
Sponsor type
Industry
First posted
Mar 21, 2019

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 50 years, up to 75 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The DELPhi system is a software device that is used for the noninvasive evaluation of brain plasticity and connectivity. The DELPhi software uses EEG and TMS devices as accessories. Standard electro-physiological acquisition is performed using TMS to evoke regional neuronal potentials measured as EEG data. TMS-EEG data is analyzed with regards to conventional, well established characteristics of neuronal network plasticity and connectivity.

Conditions

  • Stroke
  • Hypertension
  • Diabete Mellitus
  • Dyslipidemias
  • Sleep Disorder
  • Smoking
  • Overweight and Obesity
  • Familial Alzheimer Disease
  • Atrial Fibrillation
  • Cardiac Disease
  • Cognitive Impairment
  • Transient Ischemic Attack

Interventions

  • DELPhI systemDevice

    DELPhI software is acquiring and analyzing the TMS evoked response recorded with the EEG.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Establishing DELPhI's norms of population 50-75 years old at risk for stroke and dementiaTime frame: 1 visit

2 more outcomes with a free account

Locations

4 sites in 2 countries. Site status is shown where the registry gives one.

  • Diablo Clinical Research Inc.

    Walnut Creek, California

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.